tirzepatide bimagrumab A drug called apitegromab may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The This Week Lilly Stopped a

Questions to ask: Ask: "How long can my specific formulation stay at room temperature?" Ask: "Can I shift my injection day for this trip, and if so, by how much?" Ask: "Do I need any documentation for international travel with my medication?" Ask: "What should I do if my medication gets warm or freezes?" For full safety details, see Get Thin MDs Important Safety Information

adults reported taking a GLP-1 drug, with about 38% of those (about 2.3% total) taking the drug to address excess weight (Montero et al., 2024)

Routes of Administration: Intravenous (IV) administration (likely primary use)

From the comfort and privacy of your own home, you can connect with your doctor whenever you need to, with same-day appointments 24/7, even on holidays